SETD2 and cancer: Neutrophils in the cancer environment can impede CD8+ T cell-dependent immune surveillance through various mechanisms, including Kras mutation, SETD2 deficiency-induced H3K36me3 methylation, miR-146a delivery, and the production of NO, GM-CSF, and arginase-1 [40–44].